Home » Oxford Biomedica Signs Five-Year Collaboration for COVID-19 Vaccine Manufacturing
Oxford Biomedica Signs Five-Year Collaboration for COVID-19 Vaccine Manufacturing
Oxford Biomedica has signed a five-year collaboration agreement with the Vaccines Manufacturing and Innovation Center (VMIC) to manufacture viral vector-based vaccines.
The VMIC will provide manufacturing equipment to scale up the manufacturing of AstraZeneca’s COVID-19 vaccine, AZD1222.
The agreement may be expanded for Oxford Biomedica to provide manufacturing capacity for other novel viral-vector vaccine candidates.
Upcoming Events
-
07May
-
14May
-
30May